Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.
Kerr CP, Jin WJ, Liu P, Grudzinski JJ, Ferreira CA, Comas Rojas H, Oñate AJ, Kwon O, Hyun M, Bio Idrissou M, Welch Schwartz R, Vera JM, Clark PA, Adeniyi A, Takashima M, Erbe AK, Shea AG, Powers M, Pinchuk AN, Massey CF, Choi C, Hernandez R, Bednarz BP, Ong IM, Weichert JP, Morris ZS.Nat Commun. 2026 Jan 26. doi: 10.1038/s41467-026-68834-1. Online ahead of print.PMID: 41587980 Free article.
NImmuno-radiobiology: Effects of radiation therapy on immune cells, tumor microenvironment, susceptibility of tumor cells to immune-mediated destruction, and anti-tumor immunity.
Wang Y, Berg T, Verona AW, Morris ZS.Int J Radiat Oncol Biol Phys. 2026 Jan 21:S0360-3016(26)00088-X. doi: 10.1016/j.ijrobp.2026.01.013. Online ahead of print.PMID: 41577207 Review.
STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma.
MacNeil T, Hayman TJ, Li S, Moutafi M, Martinez-Morilla S, Vathiotis IA, Hu R, Harari PM, Burtness B, Liu H, Kimple RJ, Rimm DL, Contessa JN.JNCI Cancer Spectr. 2026 Jan 22:pkaf126. doi: 10.1093/jncics/pkaf126. Online ahead of print.PMID: 41569294
Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus Paper.
Puckett LL, Apisarnthanarax S, Ballas LK, Chera BS, Chetty IJ, Dawes SL, DeMarco J, Eyler CE, Goodman KA, Jacqmin D, Katsoulakis E, Bang CK, Kujundzic K, Nichols EM, Pursley J, Rosu-Bubulac M, Simone CB 2nd, Xia P, Solanki AA.Pract Radiat Oncol. 2026 Jan 21:S1879-8500(25)00305-4. doi: 10.1016/j.prro.2025.11.003. Online ahead of print.PMID: 41569222 Free article. Review.
Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers.
Cosper PF, Paracha M, Jones KM, Hrycyniak L, Henderson L, Bryan A, Eyzaguirre D, McCunn E, Boulanger E, Wan J, Nickel KP, Horner V, Hu R, Harari PM, Kimple RJ, Weaver BA.Int J Radiat Oncol Biol Phys. 2026 Jan 20:S0360-3016(25)06591-5. doi: 10.1016/j.ijrobp.2025.12.014. Online ahead of print.PMID: 41563231
Interactome screening implicates BAG6 as a suppressor of UBQLN2 misfolding in ALS/FTD.
Kim SH, Boos CE, Scalf M, Wilkemeyer AK, Smith LM, Tibbetts RS.Front Mol Neurosci. 2026 Jan 5;18:1720347. doi: 10.3389/fnmol.2025.1720347. eCollection 2025.PMID: 41561437 Free PMC article.
Divergent role of CD8 T cells with distinct metabolic phenotypes during curative radio-immunotherapy in hot versus cold tumors.
Heaton AR, Burkard NJ, Gao A, Hoefges A, Feils AS, Burkard SK, Felder MA, Tsarovsky NW, Spiegelman DV, Lublin GM, Hampton AA, D’Amato A, Dinh HQ, Rakhmilevich AL, Erbe AK, Sondel PM, Skala MC.bioRxiv [Preprint]. 2026 Jan 5:2025.10.24.684274. doi: 10.1101/2025.10.24.684274.PMID: 41279819 Free PMC article. Preprint.
Assessing the potential and pitfalls of spot sequence optimization for OAR-specific dose rate control in proton PBS Bragg peak FLASH radiotherapy.
Diao L, Zhao X, Cheng C, Zhang T, Wei S, Meng D, Wei Z, Ma Y, Zhu K, Wu H, Durkee B, Lin H, Simone CB, Yan X, Kang M.Radiother Oncol. 2026 Jan;214:111291. doi: 10.1016/j.radonc.2025.111291. Epub 2025 Nov 19.PMID: 41271173
Modality-AGnostic image Cascade (MAGIC) for multi-modality cardiac substructure segmentation.
Summerfield N, He Q, Kuo A, Ruff C, Pan J, Ghanem AI, Zhu S, Kumar A, Nagpal P, Zhao J, Dong M, Glide-Hurst C.Radiother Oncol. 2026 Jan;214:111296. doi: 10.1016/j.radonc.2025.111296. Epub 2025 Nov 19.PMID: 41271169